Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance

Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance

Nazanin Aghel,1 Diego Hernan Delgado,1 Jeffrey Howard Lipton2 1Division of Cardiology, Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network,University of Toronto, 2Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Uni...

Full description

Bibliographic Details
Main Authors: Aghel N, Delgado DH, Lipton JH
Format: Article
Language:English
Published: Dove Medical Press 2017-08-01
Series:Vascular Health and Risk Management
Subjects:
BCR-ABL
Tyrosine kinase inhibitor
peripheral arterial disease
cardiovascular disease
adverse event
Online Access:https://www.dovepress.com/cardiovascular-toxicities-of-bcr-abl-tyrosine-kinase-inhibitors-in-chr-peer-reviewed-article-VHRM

Internet

https://www.dovepress.com/cardiovascular-toxicities-of-bcr-abl-tyrosine-kinase-inhibitors-in-chr-peer-reviewed-article-VHRM

Similar Items